Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02215096
Title Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

GSK2636771

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST